Analysis of performance of Covid-19 vaccine supply chain in India

被引:1
|
作者
Nagarajan, Chandrasekaran [1 ]
Indira, A. [2 ]
Ramasubramaniam, M.
机构
[1] Krea Univ, Inst Financial Management & Res, Grad Sch Business, Sri City, India
[2] Ctr Budget & Policy Studies, Bangalore, India
关键词
COVID-19; Public health centre; Supply chain effectiveness; Vaccine supply chain; Vaccine distribution performance; Last-mile delivery; Coordination; COLD CHAIN; IMMUNIZATION; MANAGEMENT;
D O I
10.1108/JGOSS-08-2022-0096
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
PurposeThis study aims to analyse the structure of the Indian vaccine supply chain (SC) during the Covid-19 crisis and explore the underlying challenges at each stage in the network. It also brings out the difference in performance of various constituent states. Design/methodology/approachThis study relied on both primary and secondary data for the analyses. For the primary data, the study gathered experts' opinions to validate the authors' inferences. For the secondary data, it relies on government data provided in websites. FindingsBased on the quartile analysis and cluster analysis of the secondary data, the authors find that the constituent states responded differently during the first and second waves. This was due to the differences in SC characteristics attributed to varied demographics and administrative efficiency. Research limitations/implicationsThis paper's analyses is primarily limited to secondary information and inferences are based on them. The study has important implications for implementing the large-scale vaccination drives by government and constituent states for better coordination and last-mile delivery. Originality/valueThe contribution is unique in studying the performance of constituent states using statistical techniques, with secondary data from authentic sources. It is also unique in combining this observation with validation from experts.
引用
收藏
页码:247 / 270
页数:24
相关论文
共 50 条
  • [1] The Impact of IoT on the Performance of Vaccine Supply Chain Distribution in the COVID-19 Context
    Kumar, Shashank
    Raut, Rakesh D.
    Priyadarshinee, Pragati
    Mangla, Sachin Kumar
    Awan, Usama
    Narkhede, Balkrishna E.
    [J]. IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT, 2024, 71 : 13123 - 13133
  • [2] Optimal planning of the COVID-19 vaccine supply chain
    Georgiadis, Georgios P.
    Georgiadis, Michael C.
    [J]. VACCINE, 2021, 39 (37) : 5302 - 5312
  • [3] Managing supply chain aspects of the COVID-19 pandemic in India
    Ray, Anjan
    [J]. INDIAN CHEMICAL ENGINEER, 2020, 62 (04) : 396 - 401
  • [4] The influence of supply chain immunity perceptions on COVID-19 vaccine willingness in supply chain professionals
    Finkenstadt, Daniel Joseph
    Handfield, Robert
    [J]. INTERNATIONAL JOURNAL OF LOGISTICS MANAGEMENT, 2023, 34 (01) : 84 - 105
  • [5] India and the COVID-19 vaccine
    Satish, Karthyayani Priya
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [6] Age Specific Optimal Allocation of COVID-19 vaccine supply in India
    Talati, Isha
    Shah, Devanshi
    Shaikh, Azharuddin
    Patel, Amisha
    Mishra, Poonam
    [J]. JOURNAL OF APPLIED NONLINEAR DYNAMICS, 2024, 13 (01) : 27 - 35
  • [7] Supply Chain Challenges Creating Hurdles to COVID-19 Vaccine Production
    Dakin, Jonathan
    [J]. BIOPHARM INTERNATIONAL, 2021, 34 (04) : 47 - 50
  • [8] Impact of COVID-19 on agriculture supply chain in India and the proposed solutions
    Trivedi, Shantanu
    Negi, Saurav
    Anand, Neeraj
    [J]. INTERNATIONAL JOURNAL OF SUSTAINABLE AGRICULTURAL MANAGEMENT AND INFORMATICS, 2020, 6 (04) : 359 - 380
  • [9] Risks and supply chain performance: globalization and COVID-19 perspectives
    Duong, An Thi Binh
    Vo, Vinh Xuan
    do Sameiro Carvalho, Maria
    Sampaio, Paulo
    Truong, Huy Quang
    [J]. INTERNATIONAL JOURNAL OF PRODUCTIVITY AND PERFORMANCE MANAGEMENT, 2023, 72 (07) : 1962 - 1986
  • [10] COVID-19 vaccine preferences in India
    Bansal, Prateek
    Raj, Alok
    Shukla, Dhirendra Mani
    Sunder, Naveen
    [J]. VACCINE, 2022, 40 (15) : 2242 - 2246